Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 694 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
50 Results
- Brain, Spinal Cord & Nervous System
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures
- Brain, Spinal Cord & Nervous System
- Mental Health & Behavioral Research
- Gender:All Genders
- Age:18 years - 70 years
A Phase 3, Randomized,Double-Blinded, Double-Dummy Study Evaluating the Efficacy andSafety ofEmpasiprubartVersus Intravenous Immunoglobulin in Adults With Multifocal Motor Neuropathy
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
AMS05: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- Brain, Spinal Cord & Nervous System
An Open-Label, Multicenter Study of Nasal Foralumab in NonActive Secondary Progressive Multiple Sclerosis Patients
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years - 75 years
Anticoagulation for Stroke Prevention and Recovery After ICH (ASPIRE)
- Heart/Cardiovascular
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
ARGX-113-2007 A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, 2-Arm, Multicenter, Operationally Seamless Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy (ALKIVIA)
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
ARGX-113-2011: A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
Biomarkers of Clinical Subtype and Treatment Response in Obsessive-Compulsive Disorder
- Brain, Spinal Cord & Nervous System
- Mental Health & Behavioral Research
- Gender:All Genders
- Age:18 years - 70 years
Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study (PRESS)
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
1-10 of 50 Results